The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Endo, Y.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endo, Y.
Right arrow Articles by Fujita, T.
The Journal of Immunology, 1999, 162: 2180-2183.
Copyright © 1999 by The American Association of Immunologists

Molecular Basis of Human Complement C1s Deficiency

Yuichi Endo*, Kazuko Kanno*, Minoru Takahashi*, Ken-ichi Yamaguchi{dagger}, Yoichi Kohno{dagger} and Teizo Fujita*

* Department of Biochemistry, Fukushima Medical University School of Medicine, 1-Hikarigaoka, Fukushima, Japan; and {dagger} Department of Pediatrics, Chiba University School of Medicine, Inohana, Chyuo-ku, Chiba, Japan

This is the first report on the molecular basis of human complement C1s deficiency. Two abnormalities in the C1s gene were identified in a Japanese family, including one patient, by using exon-specific PCR, single-strand conformation polymorphism analysis, and nucleotide sequencing. A deletion of 4 bp, TTTG, was identified in exon X when using genomic DNA from the patient, his father, and his paternal grandmother. They were all heterozygous for the mutation. The mutant gene encodes a truncated C1s from the N terminus to the short consensus repeat domain. By further sequencing the PCR products, a nonsense mutation from G to T was identified at codon 608 in exon XII in the patient, his mother, and his sister. They were all heterozygous for the nonsense mutation. The mutant gene encodes a truncated form of C1s that lacks the C-terminal 80 amino acids. These results indicate that the patient was a compound heterozygote with the 4-bp deletion on the paternal allele and the nonsense mutation on the maternal allele. The levels of serum C1s seem to be correlated to the genotypes of the C1s gene in which no C1s was detected in the patient, and one-half of the normal level in the family members who are heterozygous for either mutation. The present study demonstrates that the disease is inherited in an autosomal recessive mode.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M.-A. Dragon-Durey, P. Quartier, V. Fremeaux-Bacchi, J. Blouin, C. de Barace, A.-M. Prieur, L. Weiss, and W.-H. Fridman
Molecular Basis of a Selective C1s Deficiency Associated with Early Onset Multiple Autoimmune Diseases
J. Immunol., June 15, 2001; 166(12): 7612 - 7616.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.